Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Recordati Ag

02 15Recordati Rare Diseases

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Sparrow

Brand Name : Signifor

Dosage Form : Solution For Injection

Dosage Strength : 0.3mg/ml

Packaging :

Approval Date : 02/11/2012

Application Number : 61254

Regulatory Info : Allowed

Registration Country : Switzerland

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Sparrow

Brand Name : Signifor

Dosage Form : Solution For Injection

Dosage Strength : 0.6mg/ml

Packaging :

Approval Date : 02/11/2012

Application Number : 61254

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotide Diaspartate

Brand Name : Significance

Dosage Form : Injectable Solution

Dosage Strength : 0.3mg

Packaging :

Approval Date : 24/04/2012

Application Number : 20101005000034

Regulatory Info : Approved

Registration Country : Sweden

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotide Diaspartate

Brand Name : Significance

Dosage Form : Injectable Solution

Dosage Strength : 0.6mg

Packaging :

Approval Date : 24/04/2012

Application Number : 20101005000041

Regulatory Info : Approved

Registration Country : Sweden

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotide Diaspartate

Brand Name : Significance

Dosage Form : Injectable Solution

Dosage Strength : 0.9mg

Packaging :

Approval Date : 24/04/2012

Application Number : 20101005000058

Regulatory Info : Approved

Registration Country : Sweden

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotidembonate

Brand Name : Significance

Dosage Form : Powder For Injection

Dosage Strength : 10mg

Packaging :

Approval Date : 18/09/2017

Application Number : 20161202000022

Regulatory Info : Approved

Registration Country : Sweden

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotidembonate

Brand Name : Significance

Dosage Form : Powder For Injection

Dosage Strength : 20mg

Packaging :

Approval Date : 19/11/2014

Application Number : 20131101000010

Regulatory Info : Approved

Registration Country : Sweden

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotidembonate

Brand Name : Significance

Dosage Form : Powder For Injection

Dosage Strength : 30mg

Packaging :

Approval Date : 18/09/2017

Application Number : 20161202000039

Regulatory Info : Approved

Registration Country : Sweden

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotidembonate

Brand Name : Significance

Dosage Form : Powder For Injection

Dosage Strength : 40mg

Packaging :

Approval Date : 19/11/2014

Application Number : 20131101000027

Regulatory Info : Approved

Registration Country : Sweden

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Pasireotidembonate

Brand Name : Significance

Dosage Form : Powder For Injection

Dosage Strength : 60mg

Packaging :

Approval Date : 19/11/2014

Application Number : 20131101000034

Regulatory Info : Approved

Registration Country : Sweden

blank